Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses

被引:105
作者
Kawano, T
Yamagata, M
Takahashi, H
Niidome, Y
Yamada, S
Katayama, Y
Niidome, T
机构
[1] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan
[2] Kyushu Univ, Ctr Future Chem, Nishi Ku, Fukuoka 8190395, Japan
基金
日本学术振兴会;
关键词
gene delivery; biodistribution; gold nanoparticle; electroporation;
D O I
10.1016/j.jconrel.2005.12.022
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This study aimed to investigate the benefits of combining the use of PEG-modified cationic gold nanoparticles with electroporation for in vivo gene delivery. PEG-modified cationic gold nanoparticles were prepared by NaBH4 reduction of HAuCl4 in the presence of 2-aminoethanethiol and mPEG-SH. Zeta-potential of the particles was nearly neutral (+0.1 mV). After forming complexes with plasmid DNA at a w/w ratio of 8.4, nanoparticle complexes were 90 nm for at least 60 min and showed a negative zeta-potential. After intravenous injection of DNA-nanoparticle complexes, 20% of gold were detected in blood at 120 min after injection and 5% of DNA were observed in blood after 5 min, suggesting that PEG-modified nanoparticles were stably circulating in the blood flow, but some of the DNA bound to particles degraded during circulation. When electroporation was applied to a lobe of the liver following injection of DNA-nanoparticle complexes, significant gene expression was specifically observed in the pulsed lobe. We concluded that PEG-modified nanoparticles maintained DNA more stably in the blood flow than in the case of naked DNA and electroporation assisted in restricted gene expression of circulating DNA in limited areas of the liver. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:382 / 389
页数:8
相关论文
共 26 条
[1]   Gene transfer into muscle by electroporation in vivo [J].
Aihara, H ;
Miyazaki, J .
NATURE BIOTECHNOLOGY, 1998, 16 (09) :867-870
[2]   An overview of current delivery systems in cancer gene therapy [J].
El-Aneed, A .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :1-14
[3]   Efficient nonviral cutaneous transfection [J].
Glasspool-Malone, J ;
Somiari, S ;
Drabick, JJ ;
Malone, RW .
MOLECULAR THERAPY, 2000, 2 (02) :140-146
[4]   Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer [J].
Harada-Shiba, M ;
Yamauchi, K ;
Harada, A ;
Takamisawa, I ;
Shimokado, K ;
Kataoka, K .
GENE THERAPY, 2002, 9 (06) :407-414
[5]   In vivo gene electroinjection and expression in rat liver [J].
Heller, R ;
Jaroszeski, M ;
Atkin, A ;
Moradpour, D ;
Gilbert, R ;
Wands, J ;
Nicolau, C .
FEBS LETTERS, 1996, 389 (03) :225-228
[6]   In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound [J].
Huber, PE ;
Pfisterer, P .
GENE THERAPY, 2000, 7 (17) :1516-1525
[7]   Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(L-lysine) in the blood flow [J].
Kawano, T ;
Okuda, T ;
Aoyagi, H ;
Niidome, T .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (02) :329-337
[8]   In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates [J].
Kwok, KY ;
Park, Y ;
Yang, YS ;
McKenzie, DL ;
Liu, YH ;
Rice, KG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) :1174-1185
[9]   Repression of GAD autoantigen expression in pancreas β-cells by delivery of antisense plasmid/PEG-g-PLL complex [J].
Lee, M ;
Han, SO ;
Ko, KS ;
Koh, JJ ;
Park, JS ;
Yoon, JW ;
Kim, SW .
MOLECULAR THERAPY, 2001, 4 (04) :339-346
[10]   Electric gene transfer to the liver following systemic administration of plasmid DNA [J].
Liu, F ;
Huang, L .
GENE THERAPY, 2002, 9 (16) :1116-1119